Refractory gastroesophageal reflux disease: advances and treatment

Expert Rev Gastroenterol Hepatol. 2014 Aug;8(6):657-67. doi: 10.1586/17474124.2014.910454. Epub 2014 Apr 19.

Abstract

'Refractory gastroesophageal reflux disease' is one of the most common misnomers in the area of gastroesophageal reflux disease. The term implies reflux as the underlying etiology despite unresponsiveness to aggressive proton pump inhibitor therapy. The term should be replaced with 'refractory symptoms.' We must acknowledge that in many patients symptoms of reflux often overlap with non-GERD causes such as gastroparesis, dyspepsia, hypersensitive esophagus and functional disorders. Lack of response to aggressive acid suppressive therapy often leads to diagnostic testing. In majority of patients these tests are normal. The role of non-acid reflux in this group is uncertain and patients should not undergo surgical fundoplication based on this parameter. In patients unresponsive to acid suppressive therapy GERD is most commonly not causal and a search for non-GERD causes must ensue.

Keywords: achalasia; acid suppressive therapy; functional upper gut symptoms; gastroparesis; refractory symptoms.

Publication types

  • Review

MeSH terms

  • Animals
  • Endoscopy, Gastrointestinal
  • Esophageal pH Monitoring
  • Esophagus / drug effects*
  • Esophagus / physiopathology
  • Gastroesophageal Reflux / classification
  • Gastroesophageal Reflux / diagnosis
  • Gastroesophageal Reflux / drug therapy*
  • Gastroesophageal Reflux / physiopathology
  • Humans
  • Manometry
  • Predictive Value of Tests
  • Proton Pump Inhibitors / therapeutic use*
  • Risk Assessment
  • Risk Factors
  • Terminology as Topic
  • Treatment Failure

Substances

  • Proton Pump Inhibitors